Board

  • Christopher Dunks – Managing Director & CEO

    BEng(Mech)

    Christopher has spent the past 20 years working on major minerals processing, refining and power projects both in Australia and the USA. Christopher was a Founder and Executive Director of ASX-listed Elementos Ltd (ASX:ELT). Christopher’s experience is in mechanical design, construction management and supervision, project controls, project management, contract negotiation, business development and new technology commercialisation.

  • Terence (Terry) Gray – Executive Director & Commercial Director

    BBus, GradDip App.Fin&Inv.

    Terence is a corporate finance professional who has deep knowledge of funds management and the Australian equity market providing expertise in company valuation, corporate financing and M&A activity.

    Terence is the principal of Tegis Pty Ltd (ACN 120 347 088) (Tegis), an investment management and corporate advisory services company and is a non-executive director of ASX listed Leaf Resources Limited (ASX:LER).

    Terence was a non-executive director of Spirit Telecom Limited, an ASX listed telecommunications company from 2014 to 2020 and chair of the audit and risk committee during his tenure. Other previous roles include Head of Equities at ANZ Funds Management, Chief Investment Officer at Allianz Equity Management, Head of Research at Allianz Dresdner Asset Management, Director of Corporate Finance at Grange Securities and Corporate Consultant nominated as a Responsible Manager for Lodge Partners stockbroking. 

  • Dr Geoff Duckworth – Executive Director & Technical Director

    B.Eng.(Chem), M.Eng.Sc., PhD, FIChemE, FAusIMM,  MIEAust,  GradDip(Tech Mgmt), RPEQ 2702

    Geoff has over 45 years of experience, predominantly in project development, process design and process design management. Geoff’s experience covers a wide spectrum of industries including oil refining, petrochemicals, inorganic chemicals, fertilisers, mineral dressing, hydrometallurgy, metals refining, food processing and effluent treatment.